There was no significant difference in the expression levels of CBR1, CCDC102A, LGALS1, SLC29A2, RD3L and TWIST1 genes between AML patients and healthy donors (Supplementary Figure 9). The gene discussed is SLC29A2; the disease is acute myeloid leukemia.